A randomized, double-blind, placebo-controlled study of gastroesophageal reflux disease therapy (lansoprazole; solutab) in the management of childhood asthma.

Trial Profile

A randomized, double-blind, placebo-controlled study of gastroesophageal reflux disease therapy (lansoprazole; solutab) in the management of childhood asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2015

At a glance

  • Drugs Lansoprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (retrospective trial: NCT01536457).
    • 10 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (retrospective trial: NCT01536457).
    • 10 Feb 2015 Planned primary completion date changed to 1 Sep, 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top